Compare CLDX & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | TNK |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 1995 | 2007 |
| Metric | CLDX | TNK |
|---|---|---|
| Price | $43.01 | $76.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $46.60 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 929.5K | 293.2K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $20.19 | $43.54 |
| 52 Week High | $42.92 | $83.99 |
| Indicator | CLDX | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 74.14 | 53.45 |
| Support Level | $28.51 | $70.54 |
| Resistance Level | N/A | $80.53 |
| Average True Range (ATR) | 1.61 | 2.68 |
| MACD | 0.54 | -0.02 |
| Stochastic Oscillator | 98.32 | 34.05 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.